News

Soleno Therapeutics Announces Presentations at the 2022 European Congress of Endocrinology

May 19, 2022

REDWOOD CITY, Calif. , May 19, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

May 17, 2022

REDWOOD CITY, Calif. , May 17, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

May 10, 2022

REDWOOD CITY, Calif. , May 10, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More